AirSculpt Technologies, Inc. (AIRS)

Market Cap	165.46M -27.3%
Revenue (ttm)	157.55M -16.5%
Net Income	-17.98M
EPS	-0.30
Shares Out	62.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,806,414
Open	2.760
Previous Close	2.720
Day's Range	2.610 - 3.130
52-Week Range	1.510 - 12.000
Beta	2.80
Analysts	Hold
Price Target	2.50 (-5.66%)
Earnings Date	May 1, 2026

About AIRS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and Air...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 29, 2021
• Employees: 422
• Stock Exchange: NASDAQ
• Ticker Symbol: AIRS
• Website: https://airsculpt.com

Financial Performance

In 2024, AirSculpt Technologies's revenue was $180.35 million, a decrease of -7.95% compared to the previous year's $195.92 million. Losses were -$8.25 million, 84.2% more than in 2023.

Analyst Summary

According to one analyst, the rating for AIRS stock is "Hold" and the 12-month stock price target is $2.5.

Price Target

$2.5

(-5.66% downside)

Analyst Consensus: Hold